These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32694196)

  • 1. Antipsychotic Behavioral Phenotypes in the Mouse Collaborative Cross Recombinant Inbred Inter-Crosses (RIX).
    Giusti-Rodríguez P; Xenakis JG; Crowley JJ; Nonneman RJ; DeCristo DM; Ryan A; Quackenbush CR; Miller DR; Shaw GD; Zhabotynsky V; Sullivan PF; Manuel de Villena FP; Zou F
    G3 (Bethesda); 2020 Sep; 10(9):3165-3177. PubMed ID: 32694196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice.
    Crowley JJ; Adkins DE; Pratt AL; Quackenbush CR; van den Oord EJ; Moy SS; Wilhelmsen KC; Cooper TB; Bogue MA; McLeod HL; Sullivan PF
    Pharmacogenomics J; 2012 Apr; 12(2):147-55. PubMed ID: 21079646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
    Naidu PS; Kulkarni SK
    Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
    Bordia T; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
    Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
    Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
    Naidu PS; Singh A; Kulkarni SK
    Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
    Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
    Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol-Induced Preclinical Tardive Dyskinesia Model in Rats.
    Guzen FP; Cavalcanti JRLP; Cavalcanti DMLP; de Sales LGP; da Silva MSM; da Silva ANA; Pinheiro FI; de Araújo DP
    Curr Protoc Neurosci; 2019 Jun; 88(1):e68. PubMed ID: 31216395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.
    Syu A; Ishiguro H; Inada T; Horiuchi Y; Tanaka S; Ishikawa M; Arai M; Itokawa M; Niizato K; Iritani S; Ozaki N; Takahashi M; Kakita A; Takahashi H; Nawa H; Keino-Masu K; Arikawa-Hirasawa E; Arinami T
    Neuropsychopharmacology; 2010 Apr; 35(5):1155-64. PubMed ID: 20072119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia.
    Naidu PS; Singh A; Kulkarni SK
    Neuropharmacology; 2003 Jun; 44(8):1100-6. PubMed ID: 12763102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
    Bordia T; Zhang D; Perez XA; Quik M
    Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol.
    Kajero JA; Seedat S; Ohaeri J; Akindele A; Aina O
    World J Biol Psychiatry; 2020 Oct; 21(8):612-626. PubMed ID: 32264772
    [No Abstract]   [Full Text] [Related]  

  • 14. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
    An HM; Tan YL; Shi J; Wang Z; Lv MH; Soares JC; Zhou D; Yang F; Zhang XY
    Phytomedicine; 2016 Dec; 23(13):1653-1660. PubMed ID: 27823630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice.
    Crowley JJ; Kim Y; Szatkiewicz JP; Pratt AL; Quackenbush CR; Adkins DE; van den Oord E; Bogue MA; Yang H; Wang W; Threadgill DW; de Villena FP; McLeod HL; Sullivan PF
    Mamm Genome; 2012 Jun; 23(5-6):322-35. PubMed ID: 22207321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias.
    Konitsiotis S; Tsironis C; Kiortsis DN; Evangelou A
    Psychopharmacology (Berl); 2006 Apr; 185(3):369-77. PubMed ID: 16518645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals.
    Patil R; Hiray Y; Shinde S; Langade P
    Pharm Biol; 2012 Jun; 50(6):691-7. PubMed ID: 22136413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.